These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 15964295)

  • 1. Vaginal distribution of two volumes of the novel microbicide gel cellulose sulfate (2.5 and 3.5 mL).
    Barnhart KT; Pretorius ES; Shaunik A; Timbers K; Nasution M; Mauck C
    Contraception; 2005 Jul; 72(1):65-70. PubMed ID: 15964295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The optimal analysis of MRI data to quantify the distribution of a microbicide.
    Barnhart KT; Pretorius ES; Shera DM; Shabbout M; Shaunik A
    Contraception; 2006 Jan; 73(1):82-7. PubMed ID: 16371301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
    Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
    Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaginal distribution of Replens and K-Y Jelly using three imaging techniques.
    Mauck CK; Katz D; Sandefer EP; Nasution MD; Henderson M; Digenis GA; Su I; Page R; Barnhart K
    Contraception; 2008 Mar; 77(3):195-204. PubMed ID: 18279691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial to determine the distribution of four topical gel formulations in the human vagina.
    Barnhart K; Kulp JL; Rosen M; Shera DM
    Contraception; 2009 Apr; 79(4):297-303. PubMed ID: 19272499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Pilot Study Measuring the Distribution and Permeability of a Vaginal HIV Microbicide Gel Vehicle Using Magnetic Resonance Imaging, Single Photon Emission Computed Tomography/Computed Tomography, and a Radiolabeled Small Molecule.
    Fuchs EJ; Schwartz JL; Friend DR; Coleman JS; Hendrix CW
    AIDS Res Hum Retroviruses; 2015 Nov; 31(11):1109-15. PubMed ID: 26077739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of a 3.5-mL (1.0%) C31G vaginal gel using magnetic resonance imaging.
    Barnhart KT; Pretorius ES; Timbers K; Shera D; Shabbout M; Malamud D
    Contraception; 2005 May; 71(5):357-61. PubMed ID: 15854637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized controlled safety trial of the diaphragm and cellulose sulfate microbicide gel in sexually active women in Zimbabwe.
    van der Straten A; Napierala S; Cheng H; Mauck C; Depineres T; Dhlakama P; Thompson M; Chipato T; Hammond N; Padian N
    Contraception; 2007 Nov; 76(5):389-99. PubMed ID: 17963865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic resonance imaging to determine the distribution of a vaginal gel: before, during, and after both simulated and real intercourse.
    Pretorius ES; Timbers K; Malamud D; Barnhart K
    Contraception; 2002 Dec; 66(6):443-51. PubMed ID: 12499038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo distribution of a vaginal gel: MRI evaluation of the effects of gel volume, time and simulated intercourse.
    Barnhart KT; Pretorius ES; Timbers K; Shera D; Shabbout M; Malamud D
    Contraception; 2004 Dec; 70(6):498-505. PubMed ID: 15541413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety trial of the vaginal microbicide cellulose sulfate gel in HIV-positive men.
    Jespers V; Buvé A; Van Damme L
    Sex Transm Dis; 2007 Jul; 34(7):519-22. PubMed ID: 17297382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaginal microbicides can interfere with nucleic acid amplification tests used for the diagnosis of Chlamydia trachomatis and Neisseria gonorrhoeae infection.
    Crucitti T; Jespers V; Van Damme L; Van Dyck E; Buvé A
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):97-9. PubMed ID: 16860515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fourteen-day safety and acceptability study of 6% cellulose sulfate gel: a randomized double-blind Phase I safety study.
    Schwartz JL; Mauck C; Lai JJ; Creinin MD; Brache V; Ballagh SA; Weiner DH; Hillier SL; Fichorova RN; Callahan M
    Contraception; 2006 Aug; 74(2):133-40. PubMed ID: 16860051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and distribution of cellulose acetate 1,2-benzenedicarboxylate (CAP), a candidate anti-HIV microbicide in rhesus macaques.
    Ratterree M; Gettie A; Williams V; Malenbaum S; Neurath AR; Cheng-Mayer C; Blanchard J
    AIDS; 2005 Oct; 19(15):1595-9. PubMed ID: 16184028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative imaging and sigmoidoscopy to assess distribution of rectal microbicide surrogates.
    Hendrix CW; Fuchs EJ; Macura KJ; Lee LA; Parsons TL; Bakshi RP; Khan WA; Guidos A; Leal JP; Wahl R
    Clin Pharmacol Ther; 2008 Jan; 83(1):97-105. PubMed ID: 17507921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Appropriateness of hydroxyethylcellulose gel as a placebo control in vaginal microbicide trials: a comparison of the two control arms of HPTN 035.
    Richardson BA; Kelly C; Ramjee G; Fleming T; Makanani B; Roberts S; Musara P; Mkandawire N; Moench T; Coletti A; Soto-Torres L; Karim SA;
    J Acquir Immune Defic Syndr; 2013 May; 63(1):120-5. PubMed ID: 23334506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women.
    El-Sadr WM; Mayer KH; Maslankowski L; Hoesley C; Justman J; Gai F; Mauck C; Absalon J; Morrow K; Mâsse B; Soto-Torres L; Kwiecien A
    AIDS; 2006 May; 20(8):1109-16. PubMed ID: 16691061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of radiolabeled small molecule permeability as a quantitative measure of microbicide candidate toxicity.
    Coleman JS; Fuchs E; Aung WS; Marzinke MA; Bakshi RP; Spiegel HML; Robinson J; Hendrix CW
    Contraception; 2016 Apr; 93(4):331-336. PubMed ID: 26772905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contraception by Ushercell (cellulose sulfate) in formulation: duration of effect and dose effectiveness.
    Anderson RA; Feathergill K; Diao XH; Chany C; Rencher WF; Zaneveld LJ; Waller DP
    Contraception; 2004 Nov; 70(5):415-22. PubMed ID: 15504382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation.
    Di Fabio S; Van Roey J; Giannini G; van den Mooter G; Spada M; Binelli A; Pirillo MF; Germinario E; Belardelli F; de Bethune MP; Vella S
    AIDS; 2003 Jul; 17(11):1597-604. PubMed ID: 12853741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.